EP Patent

EP1597266A4 — A non-cryogenic process for forming glycosides

Assigned to Bristol Myers Squibb Co · Expires 2008-02-20 · 18y expired

What this patent protects

The present invention provides a method for making glycoside compounds including the steps of: (a) lithiating an aromatic reactant having a leaving group using lithium reagent in a first microreactor under non-cryogenic conditions to form a lithiated anion species, and (b) coupli…

USPTO Abstract

The present invention provides a method for making glycoside compounds including the steps of: (a) lithiating an aromatic reactant having a leaving group using lithium reagent in a first microreactor under non-cryogenic conditions to form a lithiated anion species, and (b) coupling the lithiated anion species with a carbonyl substituted reactant to form a glycoside.

Drugs covered by this patent

Patent Metadata

Patent number
EP1597266A4
Jurisdiction
EP
Classification
—
Expires
2008-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.